Further analysis in the TCGA esophageal cancer cohort showed that AKR1C1 and AKR1C2 are downregulated in tumor tissues compared to normal tissues, and no significant difference was observed for AKR1C4. This evidence concerns the gene AKR1C4 and neoplasm.